sera – Page 75 – Communicable Diseases Research

Neutrophil extracellular traps in COVID-19

Research Article

Published on 2020-06-042022-11-01
Journal: JCI Insight [Category] COVID-19,

[키워드] absolute neutrophil count acute respiratory distress breathing room air C-reactive protein cell-free DNA chromatin circulating Cohort coronavirus disease correlated COVID-19 COVID-19 patient D-dimer determine elevated enzyme Extracellular extracellular trap Future hospitalized patient identify in vitro individuals with COVID-19 infections Infectious disease Inflammation lactate dehydrogenase lung marker mechanical ventilation Microvascular thrombosis NET NETs neutrophil Neutrophil extracellular trap Neutrophils Patient patients with COVID-19 Platelet predictive power Proteins reactants receiving regulated released Respiratory failure sera Severe case severe COVID-19 severe respiratory disease syndrome therapeutic target triggered Viral pneumonia Web
[DOI] 10.1172/jci.insight.138999 PMC 바로가기 [Article Type] Research Article

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients

Article

Published on 2020-06-012022-10-04
Journal: Nature Communications [Category] SARS, 진단, 치료기술, 치료법,

[키워드] Alter antibodies antibody B-cell B-cell epitope coronavirus COVID-19 convalescent patients COVID-19 patient diagnostic diagnostics elicit fusion peptide help human antibody response identify IgG immunodominant immunogenic linear linear epitope neutralising neutralising antibody overlapping Patient peptides Receptor binding domain Region SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 spike glycoprotein SARS-CoV-2 spike protein sera serological test serology significantly spike glycoprotein Spike protein target targets the SARS-CoV-2 vaccine candidate Vaccine development Vaccines viral infection Virus neutralisation
[DOI] 10.1038/s41467-020-16638-2 PMC 바로가기 [Article Type] Article

Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression

Articles

Published on 2020-06-012022-10-31
Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS,

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Research article

Published on 2020-05-282022-10-05
Journal: Cell [Category] 바이오마커,

Cross-sectional prevalence study of MERS-CoV in local and imported dromedary camels in Saudi Arabia, 2016-2018

Research Article

Published on 2020-05-262022-10-28
Journal: PLoS ONE [Category] Coronavirus, MERS,

Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2

Letter

Published on 2020-05-082022-10-31
Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS,

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

Protocol

Published on 2020-05-062022-10-28
Journal: Viruses [Category] COVID-19,

Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients

Letter

Published on 2020-05-022022-10-31
Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS,

[키워드] 2019 novel coronavirus acute respiratory syndrome antibody Antibody Response Antibody responses assist Asymptomatic carrier Asymptomatic carriers Clinical diagnosis Clinical symptoms collected complementary conducted Consensus coronavirus COVID-19 COVID-19 patient COVID-19 patients disease severity follow-up period groups Hospitalization Humoral response individual infected with SARS-CoV-2 information Jiangsu longitudinal pattern mitigate non-severe cases nucleic acid nucleic acid test observation period pandemic Prognosis reported responses SARS-CoV-2 sera Seroconversion seroconverted Serological testing serology testing severe cases severe COVID-19 patient swab sample symptomatic Vaccine design Viral antigen viral nucleic acid viral replication Viral RNA virus
[DOI] 10.1080/22221751.2020.1756699 PMC 바로가기 [Article Type] Letter

Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020

Research

Published on 2020-04-232022-10-31
Journal: Eurosurveillance [Category] COVID-19, SARS,

[키워드] acute respiratory syndrome antibody approach Assessing attack rate carried Combination controls coronavirus coronavirus disease COVD19 COVID-19 Critical cross-reactivity Culture detect detectable develop disease severity dose ELISA evaluate evaluated health systems healthy controls IgG and IgM IgG ELISA illness onset Immunity Impact Infection infectious dose Interpretation neutralisation test neutralization pandemic Patient plasma positive PRNT public health Public health interventions RBD RBD ELISA real time Receptor binding domain reduce reduction Result SARS-CoV-2 SARS-CoV-2 antibody Sensitivity and specificity sera Serological assay serology shown the RBD the receptor-binding domain the spike protein tissue virus
[DOI] 10.2807/1560-7917.ES.2020.25.16.2000421 PMC 바로가기 [Article Type] Research

A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays

Immunoassays

Published on 2020-04-102022-10-30
Journal: Journal of Clinical Microbiology [Category] COVID-19, MERS, SARS,